Platelet membrane phospholipids

Platelet membrane phospholipids, primarily phosphatidylserine (PS) and phosphatidylethanolamine (PE), are lipid components of the platelet plasma membrane that maintain asymmetry in resting platelets, with PS and PE confined to the inner leaflet. Upon platelet activation, scramblase activity exposes PS on the outer surface, creating a procoagulant platform that binds coagulation factors like factor IXa, factor Va, prothrombin, and factor XI to assemble tenase and prothrombinase complexes, accelerating thrombin generation and clot formation. PS enrichment reduces platelet adhesion to endothelial cells due to increased negative charge and suppresses secretion from δ-, α-, and lysosomal granules, while PE enrichment enhances lysosomal secretion and adhesion. These phospholipids influence membrane curvature, fluidity, and fusion pore stability during exocytosis, linking membrane composition directly to platelet behavior in hemostasis. Although critical for physiological clotting, their dysregulation contributes to pathological thrombosis, but they are not established as discrete therapeutic targets like receptors or enzymes; instead, drugs often indirectly modulate phospholipid exposure via activation pathways.

Other names

Platelet surface phospholipidsProcoagulant phospholipidsPhosphatidylserine (PS) and phosphatidylethanolamine (PE) in platelets